We are live on ! Find out more
NFC

Northeast Financial Consultants Portfolio holdings

AUM $2.45B
1-Year Est. Return 15.14%
This Fund
S&P 500
This Quarter Est. Return
+4.01%
1 Year Est. Return
+15.14%
3 Year Est. Return
+63.77%
5 Year Est. Return
+108.46%
10 Year Est. Return
+198.58%
AUM
$2.17B
AUM Growth
+$133M
Cap. Flow
+$61.5M
Cap. Flow %
2.83%
Top 10 Hldgs %
52.14%
Holding
294
New
5
Increased
60
Reduced
81
Closed
20

Top Sells

Rank Stock Value
1
DD icon
DuPont de Nemours
DD
+$3.44M
2
PNC icon
PNC Financial Services
PNC
+$2.79M
3
AAPL icon
Apple
AAPL
+$2.54M
4
BAC icon
Bank of America
BAC
+$2.51M
5
C icon
Citigroup
C
+$2.4M

Sector Composition

Rank Sector Weight
1 Financials 10.41%
2 Technology 9.04%
3 Healthcare 4.36%
4 Communication Services 4.12%
5 Consumer Discretionary 3.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CARR icon
251
Carrier Global
CARR
$52.4B
$240K 0.01%
3,801
PAYX icon
252
Paychex
PAYX
$43.1B
$237K 0.01%
2,000
-1,000
-33% -$122K
EXPD icon
253
Expeditors International
EXPD
$23B
$225K 0.01%
1,800
WFC.PRL icon
254
Wells Fargo 7.5% Non Cumv Perp Conv
WFC.PRL
$4.66B
$220K 0.01%
185
SJM icon
255
J.M. Smucker
SJM
$12.5B
$218K 0.01%
2,000
TSLA icon
256
Tesla
TSLA
$1.31T
$218K 0.01%
1,100
-901
-45% -$157K
ENB icon
257
Enbridge
ENB
$113B
$210K 0.01%
5,896
FITB
258
Fifth Third Bancorp
FITB
$52.2B
$208K 0.01%
5,700
CB icon
259
Chubb
CB
$134B
$204K 0.01%
800
T icon
260
AT&T
T
$168B
$191K 0.01%
10,010
-8,959
-47% -$156K
LBTYK icon
261
Liberty Global Class C
LBTYK
$3.4B
$185K 0.01%
10,386
MRBK icon
262
Meridian
MRBK
$236M
$158K 0.01%
15,000
-13,334
-47% -$127K
CLSD
263
DELISTED
Clearside Biomedical
CLSD
$121K 0.01%
6,200
ETWO
264
DELISTED
E2open Parent Holdings
ETWO
$94.3K ﹤0.01%
21,000
-16,615
-44% -$74.9K
PNBK icon
265
Patriot National Bancorp
PNBK
$136M
$73.2K ﹤0.01%
39,123
ALTM
266
DELISTED
Arcadium Lithium plc
ALTM
$52.9K ﹤0.01%
15,752
KYNB
267
Kyntra Bio
KYNB
$28.6M
$48.8K ﹤0.01%
+2,188
New +$67.6K
MGNX icon
268
MacroGenics
MGNX
$249M
$42.5K ﹤0.01%
10,000
CGTX icon
269
Cognition Therapeutics
CGTX
$97M
$40.7K ﹤0.01%
24,500
HTZWW
270
Hertz Global Holdings Warrants
HTZWW
$102M
$40.5K ﹤0.01%
16,550
+500
+3% +$1.56K
AWH
271
DELISTED
Aspira Women's Health Inc. Common Stock
AWH
$34.9K ﹤0.01%
23,436
RLYB icon
272
Rallybio
RLYB
$87M
$29.6K ﹤0.01%
2,761
AKLI
273
DELISTED
Akili Inc
AKLI
$24.6K ﹤0.01%
56,554
VERU icon
274
Veru
VERU
$47.6M
$13.7K ﹤0.01%
1,630
AON icon
275
Aon
AON
$75.6B
-600
Closed -$200K

Similar funds

Northeast Financial Consultants's Q2 2024 Portfolio in Review

As of Q2 2024, Northeast Financial Consultants held 294 positions worth $2.17B, up 6.5% from $2.04B the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Northeast Financial Consultants's Q2 2024 filing shows 5 new, 60 increased, 81 reduced and 20 closed positions. Its largest new stake was Immunome: 72,953 shares worth $883K. The largest sale was DuPont de Nemours, an estimated $3.44M.

By sector, the portfolio is most concentrated in Financials at 10% of assets, down from 10% a quarter earlier, followed by Technology and Healthcare.

  • Northeast Financial Consultants's largest Q2 2024 buy was Immunome: 72,953 shares worth $883K.
  • Northeast Financial Consultants added most to Vanguard S&P 500 ETF in Q2 2024, an estimated $22M increase.
  • Northeast Financial Consultants's biggest Q2 2024 reduction was PNC Financial Services, cutting an estimated $2.79M.
  • Northeast Financial Consultants fully exited DuPont de Nemours in Q2 2024, selling an estimated $3.44M.
  • Northeast Financial Consultants's ten largest holdings make up 52% of its $2.17B portfolio in Q2 2024.
  • Northeast Financial Consultants opened 5 new positions and closed 20 in Q2 2024.
  • Northeast Financial Consultants's portfolio value rose 6.5% quarter-over-quarter to $2.17B.

Based on Northeast Financial Consultants's 13F filing for Q2 2024, filed 15 Aug 2024.